Advances in Flexible Electronics for More Comfortable Artificial Pancreas Wearables

Managing type 1 diabetes requires constant vigilance—monitoring blood glucose, calculating insulin doses, and adjusting for meals, activity, and stress. For decades, the standard tools have been fingerstick meters, insulin pens, and conventional pumps. But a technology known as the artificial pancreas (AP) has emerged as a transformative solution, automating insulin delivery based on real-time sensor readings. While early AP systems have proven effective in improving time-in-range and reducing hypoglycemia, their hardware often remained bulky, rigid, and uncomfortable for continuous wear. Recent breakthroughs in flexible electronics are now poised to change that, promising a new generation of wearables that feel less like medical devices and more like a natural part of the body.

This article explores how advances in flexible electronics are redefining the comfort, usability, and performance of artificial pancreas wearables, and what this means for the millions of people living with diabetes worldwide.

What Is an Artificial Pancreas?

An artificial pancreas system, also called a hybrid closed-loop system, combines three key components: a continuous glucose monitor (CGM), an insulin pump, and a control algorithm that automatically adjusts insulin delivery based on CGM readings. The goal is to mimic the function of a healthy pancreas—maintaining blood glucose within a target range with minimal user intervention. The system uses real-time glucose data to calculate and deliver precise insulin doses, reducing the burden of constant decision-making for the user.

Current systems, such as Medtronic’s MiniMed 780G, Tandem’s Control-IQ, and the open-source Loop system, have demonstrated significant clinical benefits, including increased time in range and reduced hypoglycemia. However, the user experience is still hampered by the physical form of the devices. CGMs require a rigid transmitter perched on an adhesive patch, insulin pumps have a chassis that must be clipped to a belt or carried in a pocket, and tubing can snag or pull. Many users report skin irritation, device visibility under clothing, and discomfort during sleep or exercise. These limitations highlight the need for a more ergonomic and body-conforming design.

Why Flexibility Matters for Wearable Medical Devices

The human body is not flat and rigid—it bends, stretches, and moves continuously. Traditional electronics built on silicon wafers and rigid circuit boards cannot conform to these dynamic surfaces without causing discomfort or dislodging. Flexible electronics, by contrast, are constructed on bendable substrates such as polyimide, polyethylene terephthalate (PET), or thin metal foils, and often incorporate stretchable interconnects. This allows the device to follow the contours of the skin, move with the wearer, and distribute mechanical stress more evenly.

For an artificial pancreas wearable, flexibility translates directly into improved comfort, greater discretion, and more reliable sensor-tissue contact—which in turn can enhance measurement accuracy and insulin delivery efficiency. When a device bends and stretches with the skin, it reduces pressure points and minimizes motion artifacts that can interfere with glucose readings. Moreover, flexible materials can be engineered to be breathable and lightweight, making them ideal for long-term wear. The shift from rigid to flexible platforms is not merely a convenience; it is a fundamental enabler of truly wearable closed-loop systems.

Recent Innovations in Artificial Pancreas Wearables

Over the past few years, research teams around the world have made notable progress in developing flexible components specifically tailored for AP systems. These innovations span sensors, delivery mechanisms, and control units, each advancing the goal of a fully integrated and comfortable system.

Flexible Glucose Sensors

Conventional CGM sensors use a rigid needle-like electrode inserted under the skin, with a hard transmitter housing on top. New flexible sensors employ thin, bendable substrates with printed or deposited electrodes that can conform to the skin’s micro-contours. For example, researchers at the University of California, San Diego have developed a stretchable sensor patch that uses graphene-based electrodes to measure glucose in interstitial fluid with high accuracy. The patch is soft, breathable, and can be worn for up to two weeks without significant signal degradation. Another approach uses micro-needle arrays made from biocompatible polymers—these tiny projections painlessly penetrate the outermost skin layer to access interstitial fluid, eliminating the need for a rigid insertion needle.

Other groups are exploring organic electrochemical transistors (OECTs) that amplify the glucose signal directly at the sensing site, reducing noise and improving response time. These flexible sensors not only reduce pain and irritation but also maintain better contact with the tissue during movement, leading to fewer dropouts and more consistent data. The combination of soft materials and advanced transduction methods is pushing CGM accuracy to new levels while dramatically improving user comfort.

Stretchable Insulin Delivery Patches

Insulin delivery has also benefited from flexible electronics. Traditional insulin pumps use a rigid cannula inserted into subcutaneous tissue, connected to a bulky pump body. New stretchable insulin patches integrate microfluidic channels, micropumps, and reservoirs into a soft, conformable platform that adheres to the skin like a large bandage. Some designs use electrically controlled hydrogel actuators or shape-memory alloys to dispense insulin in precise doses without the need for a heavy motor or battery pack. A notable example from a team at Nature Biomedical Engineering describes a wearable artificial pancreas patch that combines a flexible glucose sensor and an insulin delivery system on a single stretchable substrate, all controlled by a thin-film microcontroller.

These patches eliminate external tubing, reduce the burden of site changes, and allow users to wear the device on less intrusive locations such as the abdomen, arm, or thigh. The integration of multiple functions into a single flexible platform simplifies the user experience and lowers the risk of accidental disconnection. Ongoing research is focused on increasing the insulin reservoir capacity and improving the reliability of micropumps over extended wear periods.

Soft Control Units and Processing Modules

The brains of an artificial pancreas—the algorithm that decides when and how much insulin to deliver—must be housed in a durable, reliable processor. Recent advances have produced flexible integrated circuits using organic thin-film transistors (OTFTs) or printed electronics. These processors can be embedded directly into the soft patch, reducing the need for a separate control pod. Although current flexible processors are slower than silicon chips, they are sufficient for the low-power, low-duty-cycle operations required for automated insulin delivery. Researchers are also exploring energy harvesting from body heat or motion to power these systems, aiming for a completely battery-free wearable.

Another approach uses flexible hybrid electronics, where rigid chips are thinned and mounted on flexible substrates, combining the computational power of silicon with the mechanical compliance of the substrate. This method allows existing control algorithms to be ported directly to flexible platforms without sacrificing performance. As fabrication techniques mature, these soft control units will become smaller, more efficient, and more capable, enabling fully autonomous closed-loop patches.

Benefits of Flexible Electronics in Artificial Pancreas Wearables

The shift from rigid to flexible electronics brings a cascade of practical advantages for people with diabetes. These benefits extend across comfort, clinical outcomes, and quality of life.

  • Enhanced Comfort and Wearability: Flexible devices cause less pressure, chafing, and skin irritation. They conform to the body during exercise, sleep, and daily activities, making 24/7 wear much more tolerable. Users report that they hardly notice the device after the first few hours, which is a stark contrast to traditional rigid systems.
  • Improved Compliance: When a device is comfortable and unobtrusive, users are more likely to keep it on consistently. Consistent use is critical for maintaining glycemic control—studies show that even short gaps in CGM wear can lead to higher glucose variability. Flexible designs reduce the temptation to remove the device, thereby improving overall diabetes management.
  • Greater Mobility and Active Lifestyle: A soft, stretchable patch does not restrict movement or catch on clothing. Users can swim, run, practice yoga, or engage in contact sports without worrying about device dislodgement or damage. This freedom is especially valuable for children and active adults who need to manage diabetes without limiting their activities.
  • Discreet Monitoring: Thin, skin-toned patches are far less visible under clothing than bulky transmitters and pumps. This reduces social stigma and allows users to manage their diabetes privately, especially in professional or social settings. The psychological benefit of not being constantly reminded of one’s condition should not be underestimated.
  • Improved Sensor Accuracy: Conformal contact between the sensor and skin reduces motion artifacts and ensures consistent access to interstitial fluid, leading to more reliable glucose readings and fewer calibration requests. Flexible sensors also exhibit less drift over time because they maintain stable contact with the tissue.
  • Reduced Skin Complications: Flexible materials can be engineered to be breathable, hypoallergenic, and permeable to moisture vapor. This minimizes the risk of contact dermatitis, maceration, and other common skin issues associated with long-term adhesive wear. Many users with sensitive skin find flexible patches far more tolerable than traditional rigid adhesives.

Challenges Facing Flexible Electronic AP Systems

Despite the promise, several obstacles remain before flexible artificial pancreas wearables become mainstream. These challenges require coordinated efforts from materials scientists, engineers, clinicians, and regulators.

Durability and Longevity

Flexible electronics must withstand repeated bending, stretching, and exposure to sweat, temperature fluctuations, and UV light without degrading performance. Current organic materials can fatigue over time, and metal interconnects may crack under cyclic stress. Researchers are exploring self-healing polymers and encapsulated conductive inks to improve device lifetime. For a wearable that may need to function reliably for a week or more, durability is a non-negotiable requirement. Accelerated aging tests and real-world wear studies are needed to validate that flexible components can match the longevity of their rigid counterparts.

Biocompatibility and Skin Safety

All materials in contact with the skin or inserted into the body must be thoroughly tested for toxicity, allergic reactions, and long-term safety. While many flexible substrates (e.g., medical-grade silicones, polyurethanes) are already approved for short-term use, newer nanomaterials such as carbon nanotubes or silver nanowires require rigorous evaluation. Regulators like the FDA demand extensive preclinical and clinical data—a process that can take years and millions of dollars. Manufacturers must also ensure that the device does not harbor bacteria or cause irritation during extended wear. Hypoallergenic adhesives and antimicrobial coatings are active areas of research.

Power Supply and Energy Efficiency

Flexible processors are less power-efficient than their rigid counterparts. Powering a sensor, control algorithm, and pump motor for several days without recharging is a significant engineering challenge. Current patches often rely on small, coin-cell batteries that add bulk and limit form factor. Advances in thin-film batteries, supercapacitors, and energy harvesting (e.g., from body heat or kinetic motion) are under active investigation but have not yet reached commercial viability for AP systems. Some groups are exploring wireless power transfer using resonant charging pads, but this adds inconvenience. A breakthrough in low-power flexible electronics or high-density flexible batteries would accelerate adoption.

Data Transmission and Connectivity

Many AP systems communicate wirelessly with a smartphone or dedicated receiver. Flexible electronics must integrate reliable, low-power Bluetooth or near-field communication (NFC) antennas without compromising flexibility. Maintaining a stable wireless link while the device is bending and stretching is non-trivial. Additionally, data security and privacy must be addressed, as insulin delivery decisions are increasingly driven by cloud-based algorithms. The antenna design must be robust against deformation, and the communication protocol should minimize power consumption to extend battery life. Encryption and authentication standards also need to be integrated into the flexible platform.

Standardization and Manufacturing Scalability

Producing flexible electronic devices at scale with consistent quality remains expensive and technically demanding. Unlike silicon chip fabrication, which benefits from decades of refinement, the manufacturing processes for printed or organic electronics are still evolving. Yield rates, cost per unit, and testing protocols need to improve before flexible AP systems can compete with existing devices on price and reliability. Roll-to-roll printing techniques offer a path to low-cost, high-volume production, but they require tight control over material properties and layer alignment. Industry standards for flexible medical electronics are still in their infancy, and regulatory pathways for these novel devices are still being defined.

Future Directions and Emerging Research

The future of flexible electronics in diabetes management is bright, driven by innovations in materials science, microfabrication, and artificial intelligence. Several exciting avenues promise to further enhance the comfort and capability of artificial pancreas wearables.

Biodegradable and Dissolvable Electronics

One fascinating research avenue involves electronics that can safely degrade in the body after use, eliminating the need for removal. Such devices could be implanted temporarily for acute monitoring or drug delivery, then dissolve without trace. For an artificial pancreas, this might mean an internal sensor that biodegrades after a predetermined period, reducing foreign body reactions and surgical explantation. Early prototypes using biodegradable polymers and dissolvable metals have shown promise in animal studies, but human trials are likely years away.

Self-Calibrating and AI-Enhanced Sensors

Machine learning algorithms can process sensor data to detect drift, calibrate readings automatically, and even predict sensor failure before it occurs. Integrating these algorithms into flexible processors will enable devices that maintain accuracy without requiring the user to perform periodic fingerstick calibrations. Moreover, AI could optimize insulin delivery profiles based on an individual’s activity, stress, and sleep patterns, making the AP truly intelligent. Flexible platforms are well-suited to host these algorithms because they can be updated over the air, adapting to the user's changing physiology over time.

Fully Integrated, Closed-Loop Patches

The holy grail is a single, disposable patch that contains a flexible glucose sensor, an insulin reservoir, micro-pumps, control circuitry, and a tiny power source—all soft and stretchable. Several academic groups and startups are pursuing this vision. A 2023 paper in Science Advances demonstrated a prototype patch that maintained glucose control in diabetic pigs for over a week with minimal drift. Human trials are expected to follow once regulatory hurdles are addressed. Such a patch would eliminate tubing, separate transmitters, and bulky controllers, offering a truly seamless experience.

Dual-Hormone and Multi-Drug Delivery

Once the platform is perfected, the same flexible electronics could deliver other hormones, such as glucagon for preventing severe hypoglycemia, or even integrate closed-loop control for type 2 diabetes management. This broader application could open new markets and scale up production, driving costs down. Dual-hormone systems have shown clinical benefits in reducing hypoglycemia, and a flexible patch that can handle multiple reservoirs would simplify the user experience. Additionally, the platform could be adapted for other chronic conditions requiring continuous drug delivery, such as hormone replacement or pain management.

Conclusion

The convergence of flexible electronics with artificial pancreas technology represents a paradigm shift in diabetes care. By replacing rigid, uncomfortable components with soft, conformable, and discreet wearables, these advances promise to make 24/7 glucose management far more tolerable—and therefore more effective. While challenges in durability, power, and manufacturing remain, the pace of innovation is accelerating. As research translates into products, people with diabetes can look forward to devices that not only keep them safer but also allow them to forget, even for a few hours, that they are managing a chronic condition.

For further reading on the clinical benefits of closed-loop systems, refer to the American Diabetes Association and JDRF. For the latest in flexible sensor technology, Nature Reviews Materials offers comprehensive reviews on the subject. Industry updates on wearable medical devices can also be found through the Diabetes Technology Society.